This report series examines quarterly trends in life sciences venture investment. Key findings for Q3 2023 include:
Life sciences VC deal value in Q3 2023 totaled $7.7 billion, representing an uptick from last quarter across fewer deals. Total deal value has grown each quarter in 2023 for a year-to-date (YTD) total of $21.4 billion, compared with $28.9 billion closed in the same period in 2022.
Please see full publication below for more information.